The study identifies the IRE1α/XBP1 arm of the ER stress-induced unfolded protein response as a key driver of skeletal muscle wasting and demonstrates that its genetic or pharmacological inhibition can attenuate the loss of skeletal muscle mass and function during pancreatic cancer-induced cachexia. This evidence concerns the gene ERN1 and Cachexia.